LAVA Therapeutics NV (LAVA Therapeutics NV) Marketable Securities : $51.39 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. LAVA Therapeutics NV's Marketable Securities for the quarter that ended in Mar. 2024 was $51.39 Mil.

LAVA Therapeutics NV's annual Marketable Securities declined from Dec. 2021 ($42.33 Mil) to Dec. 2022 ($32.54 Mil) but then increased from Dec. 2022 ($32.54 Mil) to Dec. 2023 ($51.34 Mil).

LAVA Therapeutics NV Marketable Securities Historical Data

The historical data trend for LAVA Therapeutics NV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LAVA Therapeutics NV Marketable Securities Chart

LAVA Therapeutics NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

42.33

32.54

51.34

LAVA Therapeutics NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial													24.83	24.80	41.96	51.34	51.39

LAVA Therapeutics NV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

LAVA Therapeutics NV (NAS:LVTX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

LAVA Therapeutics NV Marketable Securities Related Terms

Thank you for viewing the detailed overview of LAVA Therapeutics NV's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

LAVA Therapeutics NV (LAVA Therapeutics NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (NAS:LVTX) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

4PKB:Germany

Address

Yalelaan 62, Utrecht, UT, NLD, 3584 CM

Website

https://www.lavatherapeutics.com

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.